Adaptimmune Therapeutics PLC ADR buy BiotechBee
Start price
29.04.24
/
50%
€1.12
Target price
31.07.26
€1.70
Performance (%)
-1.79%
End price
06.07.24
€1.10
Summary
This prediction ended on 06.07.24 with a price of €1.10. With a performance of -1.79%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has a follow-up prediction for Adaptimmune Therapeutics PLC ADR where he still thinks Adaptimmune Therapeutics PLC ADR is a Buy. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Adaptimmune Therapeutics PLC ADR | -2.632% | -2.632% |
| iShares Core DAX® | -0.543% | 1.491% |
| iShares Nasdaq 100 | -2.696% | -1.235% |
| iShares Nikkei 225® | -2.863% | 2.491% |
| iShares S&P 500 | -1.105% | 0.013% |
According to BiotechBee what are the pros and cons of Adaptimmune Therapeutics PLC ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Adaptimmune Therapeutics PLC ADR diskutieren
In the thread Trading Adaptimmune Therapeutics PLC ADR
Current prediction by BiotechBee for Adaptimmune Therapeutics PLC ADR
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.11
22.07.24
22.07.24
€2.00
30.09.26
30.09.26
0.00%
22.07.24
22.07.24
Could be very worthwhile Investment >20% year
Stopped prediction by BiotechBee for Adaptimmune Therapeutics PLC ADR
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.10
07.07.24
07.07.24
€2.00
31.08.25
31.08.25
0.91%
22.07.24
22.07.24
Could be very worthwhile Investment >20% year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€0.98
04.02.24
04.02.24
€1.50
31.10.25
31.10.25
14.29%
29.04.24
29.04.24
Could be very worthwhile Investment >20% year